Safe and Effective Opioid Prescribing for Chronic Pain

November 17, 2012
Grappone Conference Center, Concord, NH

 

Accreditation | Agenda | Faculty | Registration


Safe & Effective Opioid Prescribing for Chronic Pain

 

Faculty

Daniel P. Alford, MD, MPH, FACP, FASAM (Course Director)
Associate Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regard to commercial support.
Faculty member indicates that he does not plan to discuss unlabeled/investigational uses of a commercial product.
dan.alford@bmc.org

Jeffrey Baxter, MD
Assistant Professor
Department of Family Medicine and Community Health
University of Massachusetts Medical School
Faculty member has nothing to disclose with regards to commercial support.
Faculty member indicates that he does plan to discuss unlabeled/investigational uses of a commercial product:  clonidine for management of opioid withdrawal.
jeff.baxter@umassmed.edu

Kathryn Bradley
Executive Director
New Hampshire Board of Medicine
Faculty member has nothing to disclose with regard to commercial support.
Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.
kathryn.bradley@nh.gov

Seddon Savage, MD
Director, Dartmouth Center on Addiction Recovery and Education (DCARE)
Associate Professor of Anesthesiology
Dartmouth Medical School
Hanover, NH
Faculty member has nothing to disclose with regard to commercial support.
Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.
Seddon.R.Savage@dartmouth.edu

Colleen Labelle, RN, CARN (CNE Course Advisor)
Department of Internal Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regard to commercial support.

colleen.labelle@bmc.org

 

Panelists

Trooper First Class Marc Beaudoin
NH State Police
Faculty member has nothing to disclose with regard to commercial support.
Faculty member indicates that he does not plan to discuss unlabeled/investigational uses of a commercial product.

Nancy Coffey
Program Manager, New England Division
US Drug Enforcement Administration
Faculty member has nothing to disclose with regard to commercial support.
Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.

Chris Schambarger, R.Ph.
NH State Police
Faculty member has nothing to disclose with regard to commercial support.
Faculty member indicates that he does not plan to discuss unlabeled/investigational uses of a commercial product.


Conference Planner Ilana Hardesty, and Lead Nurse Planner Patti-Ann Collins, Boston University School of Medicine CME Office, have nothing to disclose with regard to commercial support.